Dermagraft-TC - Revision history

WikiModEn2: Wikify.

2022-10-29T19:27:07Z

Wikify.

← Older revision		Revision as of 19:27, 29 October 2022
Line 1:		Line 1:
	[[Image:Dermagraft.png\|right\|thumb\|]]		[[Image:Dermagraft.png\|right\|thumb\|]]
	'''Dermagraft-TC''' is an artifical [[skin]] created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb		'''Dermagraft-TC''' is an artifical [[skin]] created from harvested [[foreskin\| foreskins]] from infant [[circumcision]].<ref name='Advanced Biohealing, 2010'>{{REFweb
	\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.		\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
	\|url=http://www.dermagraft.com/about/overview/		\|url=http://www.dermagraft.com/about/overview/

WikiAdmin: wikify skin

2021-12-27T14:22:12Z

wikify skin

← Older revision		Revision as of 14:22, 27 December 2021
Line 1:		Line 1:
	[[Image:Dermagraft.png\|right\|thumb\|]]		[[Image:Dermagraft.png\|right\|thumb\|]]
	'''Dermagraft-TC''' is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb		'''Dermagraft-TC''' is an artifical [[skin]] created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb
	\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.		\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
	\|url=http://www.dermagraft.com/about/overview/		\|url=http://www.dermagraft.com/about/overview/
Line 11:		Line 11:
	\|accessdate=2011-03-06		\|accessdate=2011-03-06
	}}</ref> It is made and sold by [[Advanced Tissue Sciences]] (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb		}}</ref> It is made and sold by [[Advanced Tissue Sciences]] (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb
	\|quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.		\|quote=...fibroblast-derived temporary [[skin]] substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
	\|url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation		\|url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
	\|title=Dermagraft-TC		\|title=Dermagraft-TC
Line 27:		Line 27:
	\|date=2007-03-28		\|date=2007-03-28
	\|publisher=Transplant News		\|publisher=Transplant News
	\|quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.		\|quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary [[skin]] substitute to be approved.
	\|accessdate=2011-03-06		\|accessdate=2011-03-06
	}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal		}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of [[skin]].<ref>{{REFjournal
	\|last=Daecher		\|last=Daecher
	\|init=M		\|init=M

WikiAdmin: using singular name for category

2021-11-29T13:13:56Z

using singular name for category

← Older revision		Revision as of 13:13, 29 November 2021
Line 48:		Line 48:
	{{REF}}		{{REF}}

	[[Category:Foreskin ~~products~~]]		[[Category:Foreskin product]]
	[[Category:Financial gain]]		[[Category:Financial gain]]

WikiAdmin: adjusted REFjournal

2020-12-29T22:22:02Z

adjusted REFjournal

← Older revision		Revision as of 22:22, 29 December 2020
Line 31:		Line 31:
	}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal		}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal
	\|last=Daecher		\|last=Daecher
	\|~~first~~=M.		\|init=M
	\|title=Circumcision		\|title=Circumcision
	\|journal=Icon		\|journal=Icon

WikiAdmin: wikified ATS

2020-02-09T10:17:14Z

wikified ATS

← Older revision		Revision as of 10:17, 9 February 2020
Line 1:		Line 1:
	[[Image:Dermagraft.png\|right\|thumb\|]]		[[Image:Dermagraft.png\|right\|thumb\|]]
	'''Dermagraft-TC''' ~~which~~ is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb		'''Dermagraft-TC''' is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb
	\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.		\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
	\|url=http://www.dermagraft.com/about/overview/		\|url=http://www.dermagraft.com/about/overview/
Line 10:		Line 10:
	\|date=		\|date=
	\|accessdate=2011-03-06		\|accessdate=2011-03-06
	}}</ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb		}}</ref> It is made and sold by [[Advanced Tissue Sciences]] (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb
	\|quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.		\|quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
	\|url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation		\|url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation

WikiAdmin: add interlanguage link

2019-11-21T20:15:38Z

add interlanguage link

← Older revision		Revision as of 20:15, 21 November 2019
Line 53:		Line 53:
	[[Category:From CircLeaks]]		[[Category:From CircLeaks]]
	[[Category:From IntactWiki]]		[[Category:From IntactWiki]]

			[[de:{{FULLPAGENAME}}]]

WikiAdmin: remove parameter

2019-10-19T20:39:51Z

remove <coauthors> parameter

← Older revision		Revision as of 20:39, 19 October 2019
Line 1:		Line 1:
	[[Image:Dermagraft.png\|right\|thumb\|]]		[[Image:Dermagraft.png\|right\|thumb\|]]
	Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb		'''Dermagraft-TC''' which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb
	\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.		\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
	\|url=http://www.dermagraft.com/about/overview/		\|url=http://www.dermagraft.com/about/overview/
Line 23:		Line 23:
	\|last=		\|last=
	\|first=		\|first=
	~~\|coauthors=~~
	\|url=http://www.highbeam.com/doc/1G1-47248437.html		\|url=http://www.highbeam.com/doc/1G1-47248437.html
	\|title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA		\|title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA

WikiAdmin: decapitalize category names

2019-10-19T18:32:30Z

decapitalize category names

← Older revision		Revision as of 18:32, 19 October 2019
Line 49:		Line 49:
	{{REF}}		{{REF}}

	[[Category:Foreskin ~~Products~~]]		[[Category:Foreskin products]]
	[[Category:Financial ~~Gain~~]]		[[Category:Financial gain]]

	[[Category:From CircLeaks]]		[[Category:From CircLeaks]]
	[[Category:From IntactWiki]]		[[Category:From IntactWiki]]

WikiAdmin: remove parameter

2019-10-15T13:38:59Z

remove <coauthors> parameter

← Older revision		Revision as of 13:38, 15 October 2019
Line 1:		Line 1:
	[[Image:Dermagraft.png\|right\|thumb\|]]		[[Image:Dermagraft.png\|right\|thumb\|]]
	Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb		Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb
	\| quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.		\|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
	\| url=http://www.dermagraft.com/about/overview/		\|url=http://www.dermagraft.com/about/overview/
	\| title=Dermagraft-TC: Overview		\|title=Dermagraft-TC: Overview
	\| last=		\|last=
	\| first=		\|first=
	\| publisher=Advanced Biohealing, Inc.		\|publisher=Advanced Biohealing, Inc.
	\| website=		\|website=
	\| date=		\|date=
	\| accessdate=2011-03-06		\|accessdate=2011-03-06
	}}</ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb		}}</ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb
	\| quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.		\|quote=...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
	\| url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation		\|url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
	\| title=Dermagraft-TC		\|title=Dermagraft-TC
	\| last=		\|last=
	\| first=		\|first=
	\| publisher=MediLexicon		\|publisher=MediLexicon
	\| website=		\|website=
	\| date=		\|date=
	\| accessdate=2011-03-06		\|accessdate=2011-03-06
	}}</ref><ref name='Transplant News 2007-03-28'>{{REFnews		}}</ref><ref name='Transplant News 2007-03-28'>{{REFnews
	\| last=		\|last=
	\| first=		\|first=
	\| coauthors=		\|coauthors=
	\| url=http://www.highbeam.com/doc/1G1-47248437.html		\|url=http://www.highbeam.com/doc/1G1-47248437.html
	\| title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA		\|title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA
	\| date=2007-03-28		\|date=2007-03-28
	\| publisher=Transplant News		\|publisher=Transplant News
	\| quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.		\|quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
	\| accessdate=2011-03-06		\|accessdate=2011-03-06
	}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal		}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal
	\| last=Daecher		\|last=Daecher
	\| first=M.		\|first=M.
	~~\| coauthors=~~		\|title=Circumcision
	\| title=Circumcision		\|journal=Icon
	\| journal=Icon		\|date=1998
	\| date=1998		\|volume=2
	\| volume=2		\|issue=2
	\| issue=2		\|pages=70-73
	\| pages=70-73		\|url=
	\| url=		\|quote=
	\| quote=		\|pubmedID=
	\| pubmedID=		\|pubmedCID=
	\| pubmedCID=		\|DOI=
	\| DOI=		\|accessdate=
	\| accessdate=
	}}</ref>		}}</ref>

WikiAdmin at 17:02, 20 September 2019

2019-09-20T17:02:04Z

← Older revision		Revision as of 17:02, 20 September 2019
Line 7:		Line 7:
	\| first=		\| first=
	\| publisher=Advanced Biohealing, Inc.		\| publisher=Advanced Biohealing, Inc.
	\| ~~work~~=		\| website=
	\| date=		\| date=
	\| accessdate=2011-03-06		\| accessdate=2011-03-06
Line 17:		Line 17:
	\| first=		\| first=
	\| publisher=MediLexicon		\| publisher=MediLexicon
	\| ~~work~~=		\| website=
	\| date=		\| date=
	\| accessdate=2011-03-06		\| accessdate=2011-03-06
Line 30:		Line 30:
	\| quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.		\| quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
	\| accessdate=2011-03-06		\| accessdate=2011-03-06
	}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>~~Circumcision.~~ Daecher M. Icon 1998;2(2):70-3.</ref>		}}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref>{{REFjournal
			\| last=Daecher
			\| first=M.
			\| coauthors=
			\| title=Circumcision
			\| journal=Icon
			\| date=1998
			\| volume=2
			\| issue=2
			\| pages=70-73
			\| url=
			\| quote=
			\| pubmedID=
			\| pubmedCID=
			\| DOI=
			\| accessdate=
			}}</ref>

	{{REF}}		{{REF}}